Literature DB >> 8251140

Triglyceride-rich lipoproteins and atherosclerosis, from fast to feast.

G Steiner1.   

Abstract

There is increasing evidence that fasting hypertriglyceridaemia identifies individuals who are at increased risk for coronary artery disease. It is probable that this reflects the effects of the smaller triglyceride-bearing lipoproteins. It may also reflect increased levels of postprandial lipoproteins. There is considerable theoretical and experimental evidence to support an atherogenic role for the smaller, triglyceride-rich postprandial lipoproteins. Cross-sectional studies in humans also indicate that those with coronary disease have increased levels of postprandial lipids, probably in the remnants of chylomicrons. Recently we have completed a study examining the progression of coronary atherosclerosis angiographically. The study showed that the progression was linearly related to the numbers of chylomicron remnant particles, as reflected by the quantity of apoB48 in Sf20-60 lipoproteins, in the postprandial circulation. This paper reviews these studies, the physiology of postprandial lipoprotein metabolism and the therapeutic implications of this information.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8251140     DOI: 10.3109/07853899309147307

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  5 in total

Review 1.  Dietary cholesterol and egg yolks: not for patients at risk of vascular disease.

Authors:  J David Spence; David J A Jenkins; Jean Davignon
Journal:  Can J Cardiol       Date:  2010-11       Impact factor: 5.223

2.  Smoking, inflammatory patterns and postprandial hypertriglyceridemia.

Authors:  Edmond K Kabagambe; Jose M Ordovas; Michael Y Tsai; Ingrid B Borecki; Paul N Hopkins; Stephen P Glasser; Donna K Arnett
Journal:  Atherosclerosis       Date:  2008-08-13       Impact factor: 5.162

Review 3.  Clinical pharmacokinetics of fibric acid derivatives (fibrates).

Authors:  D B Miller; J D Spence
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

4.  Genomics of Postprandial Lipidomics in the Genetics of Lipid-Lowering Drugs and Diet Network Study.

Authors:  Marguerite R Irvin; May E Montasser; Tobias Kind; Sili Fan; Dinesh K Barupal; Amit Patki; Rikki M Tanner; Nicole D Armstrong; Kathleen A Ryan; Steven A Claas; Jeffrey R O'Connell; Hemant K Tiwari; Donna K Arnett
Journal:  Nutrients       Date:  2021-11-10       Impact factor: 5.717

5.  Sex-associated effect of CETP and LPL polymorphisms on postprandial lipids in familial hypercholesterolaemia.

Authors:  Katherine K Anagnostopoulou; Genovefa D Kolovou; Peggy M Kostakou; Constantinos Mihas; Georgios Hatzigeorgiou; Christina Marvaki; Dimitrios Degiannis; Dimitri P Mikhailidis; Dennis V Cokkinos
Journal:  Lipids Health Dis       Date:  2009-06-26       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.